Results 281 to 290 of about 20,137,277 (389)

The support of Quality Management to sustainable development: a literature review

, 2016
Vanajah Siva, Ida Gremyr, B. Bergquist, Rickard Garvare, T. Zobel, Raine Isaksson   +5 more
semanticscholar   +1 more source

Agreement of Administrative Pharmacy Dispensing With Self‐Reported Use of Oral Prednisone in US Veterans With Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective Administrative claims are used to evaluate oral glucocorticoid use in rheumatoid arthritis (RA), despite limited evidence to support accuracy. We aimed to evaluate the performance of claims‐based algorithms for glucocorticoid use compared to self‐report in an RA population.
Beth I. Wallace, Bryant R. England, Joshua F. Baker, Michael D. George, Brian C. Sauer, Jorge Rojas, Punyasha Roul, Katherine D. Wysham, Hannah Brubeck, Isaac Smith, Liron Caplan, Paul A. Monach, Gail S. Kerr, Gary Kunkel, Tawnie Braaten, Ted R. Mikuls, Grant W. Cannon   +16 more
wiley   +1 more source

Enhanced Diagnostic Precision in Revisited Emergency Patients via Point-of-Care Ultrasound: A Tool for Emergency Department Quality Management. [PDF]

J Multidiscip Healthc
Ienghong K, Khemtong S, Cheung LW, Apiratwarakul K.   +3 more
europepmc   +1 more source

Time trends and predictors of gout remission over six years

Arthritis Care &Research, Accepted Article.
Objectives This study aims to describe the trends in remission rates over six years of follow‐up among people with gout taking urate‐lowering therapy (ULT), and to identify variables that predict remission. Methods A post hoc analysis was conducted using data from the Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (CARES ...
Adwoa Dansoa Tabi‐Amponsah, Sarah Stewart, Greg Gamble, Lisa K Stamp, William J Taylor, Nicola Dalbeth   +5 more
wiley   +1 more source

Real-Time, Risk-Based Clinical Trial Quality Management in China: Development of a Digital Monitoring Platform.

JMIR Med Inform
Jiang M, Zhao S, Mei Y, Fu Z, Yuan Y, Ai J, Sheng Y, Gong Y, Chen J.   +8 more
europepmc   +1 more source

Where, how, and how much? A multicenter cohort study of the relationship between lupus decision aid modality, place of administration, interruption and viewing completeness and patient‐reported outcomes

Arthritis Care &Research, Accepted Article.
Objective We assessed whether shared decision‐making (SDM), and patient acceptability, feasibility, and overall satisfaction with a computerized patient decision aid (PtDA) for patients with systemic lupus erythematosus (SLE), differs by PtDA setting, modality, and the viewing experience.
Jasvinder A. Singh, Mark Beasley, Larry R. Hearld, for the Implementing DEcision‐Aid for Lupus in clinics (IDEAL) Consortium   +3 more
wiley   +1 more source

The Role of Total Quality Management in the Pharmaceutical, Food, and Nutritional Supplement Sectors. [PDF]

Foods
Vassos V, Voltezou A, Stavropoulos A, Stavropoulou E, Stefanis C, Tsigalou C, Nena E, Chatzaki E, Constantinidis TC, Bezirtzoglou E.   +9 more
europepmc   +1 more source

Drinking Water Quality Management on Micro-Pollutants.

, 1991
Masao Nii
openalex   +2 more sources

Treating lupus nephritis patients to lupus low disease activity reduces renal relapse and preserves long‐term kidney function

Arthritis Care &Research, Accepted Article.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE) but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment, and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond YH Yap, KL Lee, Philip H Li, Iris YK Tang, Chak Sing Lau, Shirley CW Chan   +6 more
wiley   +1 more source

Quality Management Outweighs Pandemic: Retrospective Analysis Shows Improved Quality of Care for <i>Staphylococcus aureus</i> Bacteremia Despite SARS-CoV-2. [PDF]

Diseases
Jakoby L, Molitor E, Mutters NT, Weppler R, Rauschning D, Döhla M.   +5 more
europepmc   +1 more source